UAE approves emergency use of Pfizer-BioNTech vaccine for 12-15 age group

The approval supports the national efforts to address the coronavirus (COVID-19) pandemic and protect this age group

  
A healthcare worker holds a syringe and a Pfizer-BioNTech COVID-19 vaccine vial during a coronavirus vaccination campaign at Saint George Hospital University Medical center, in Beirut, Lebanon February 14, 2021. Image for illustrative purposes.

A healthcare worker holds a syringe and a Pfizer-BioNTech COVID-19 vaccine vial during a coronavirus vaccination campaign at Saint George Hospital University Medical center, in Beirut, Lebanon February 14, 2021. Image for illustrative purposes.

REUTERS/Mohamed Azakir

ABU DHABI- In line with the National COVID-19 Vaccination Plan, the Ministry of Health and Prevention (MoHAP) approved the emergency use of the Pfizer- BioNTech vaccine for the 12 to 15 age group, under the outcomes of clinical trials and a strict assessment conducted to approve the emergency local use of the vaccine.

The approval supports the national efforts to address the coronavirus (COVID-19) pandemic and protect this age group, highlighting the UAE’s proactive approach to ensuring the community’s health and safety.

The MoHAP, the Department of Health-Abu Dhabi (DoH), the Abu Dhabi Public Health Centre (ADPHC) and the Dubai Health Authority (DHA) launched a free national vaccination campaign for all citizens and residents to curb the spread of COVID-19.

The UAE has provided over 11 million vaccine doses to citizens and residents around the country, which contributed to delivering the declared target of vaccinating half of the eligible population by the end of March 2021.

© Copyright Emirates News Agency (WAM) 2021.

More From Health